Cargando…

Design, development, and characterization of amorphous rosuvastatin calcium tablets

This work proposes a methodology for the design, development, optimisation, and evaluation of amorphous rosuvastatin calcium tablets (BCS class II drug). The main goal was to ensure rapid disintegration and high dissolution rate of the active ingredient, thus enhancing its bioavailability. The desig...

Descripción completa

Detalles Bibliográficos
Autores principales:	González, Rocío, Peña, Mª Ángeles, Torres, Norma Sofía, Torrado, Guillermo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936501/ https://www.ncbi.nlm.nih.gov/pubmed/35312730 http://dx.doi.org/10.1371/journal.pone.0265263

Ejemplares similares

Development of a formulation of potassium iodide tablets as an antidote against nuclear incidents
por: de Dios Azorín Abraham, Juan, et al.
Publicado: (2023)

Exploring the molecular reorientations in amorphous rosuvastatin calcium
por: Belozerova, N. M., et al.
Publicado: (2020)

Formulation and Evaluation of Loperamide HCl Oro Dispersible Tablets
por: Alejandro, Blasco, et al.
Publicado: (2020)

Study of Different Chitosan/Sodium Carboxymethyl Cellulose Proportions in the Development of Polyelectrolyte Complexes for the Sustained Release of Clarithromycin from Matrix Tablets
por: Guarnizo-Herrero, Víctor, et al.
Publicado: (2021)

A New Improved RP-HPLC Method for Assay of Rosuvastatin Calcium in Tablets
por: Kaila, H. O., et al.
Publicado: (2010)

Multilayer-Coated Tablet of Clopidogrel and Rosuvastatin: Preparation and In Vitro/In vivo Characterization
por: Seo, Ki-Soo, et al.
Publicado: (2019)

The application of qNMR for the determination of rosuvastatin in tablet form
por: DİKMEN, Gökhan, et al.
Publicado: (2021)

Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study
por: Elsayed, Mahmoud M. A., et al.
Publicado: (2022)

Amorphous Calcium Phosphate and Amorphous Calcium Phosphate Carboxylate: Synthesis and Characterization
por: Indurkar, Abhishek, et al.
Publicado: (2023)

Preparation and optimization of microemulsion of rosuvastatin calcium
por: Patel, Zalak B., et al.
Publicado: (2012)

Directly compressed rosuvastatin calcium tablets that offer hydrotropic and micellar solubilization for improved dissolution rate and extent of drug release
por: Butt, Sharonia, et al.
Publicado: (2019)

Amorphous Nanoparticulate Formulation of Sirolimus and Its Tablets
por: Shen, Yudong, et al.
Publicado: (2018)

Assessment of the stability of co-amorphous olanzapine in tablets
por: da Costa, Nuno F., et al.
Publicado: (2021)

Fabrication and characterization of orodispersible films loaded with solid dispersion to enhance Rosuvastatin calcium bioavailability
por: Zaki, Randa Mohammed, et al.
Publicado: (2023)

Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique
por: Kapure, V. J., et al.
Publicado: (2013)

In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets
por: Mudie, Deanna M., et al.
Publicado: (2021)

Development and Characterization of Eudragit(®) EPO-Based Solid Dispersion of Rosuvastatin Calcium to Foresee the Impact on Solubility, Dissolution and Antihyperlipidemic Activity
por: Inam, Sana, et al.
Publicado: (2022)

Tripling the Bioavailability of Rosuvastatin Calcium Through Development and Optimization of an In-Situ Forming Nanovesicular System
por: Elsayed, Ibrahim, et al.
Publicado: (2019)

Enhancing Pharmacokinetics and Pharmacodynamics of Rosuvastatin Calcium through the Development and Optimization of Fast-Dissolving Films
por: Ashraf, Ibrahim, et al.
Publicado: (2023)

Rosuvastatin calcium nanoparticles: Improving bioavailability by formulation and stabilization codesign
por: Alshora, Doaa H., et al.
Publicado: (2018)

Pharmacokinetic and pharmacodynamic interaction of Rosuvastatin calcium with guggulipid extract in rats
por: Asad, Mohammed, et al.
Publicado: (2021)

An innovative combination of Box-Behnken design and ecofriendly approaches for the simultaneous determination of aspirin, clopidogrel, atorvastatin and rosuvastatin in their fixed-dose combination tablets
por: Mostafa, Eman A., et al.
Publicado: (2023)

Relative bioavailability of ertugliflozin tablets containing the amorphous form versus tablets containing the cocrystal form
por: Sahasrabudhe, Vaishali, et al.
Publicado: (2022)

Development of Chitosan/Sodium Carboxymethylcellulose Complexes to Improve the Simvastatin Release Rate: Polymer/Polymer and Drug/Polymer Interactions’ Effects on Kinetic Models
por: López-Manzanara Pérez, Celia, et al.
Publicado: (2023)

A Novel Validated UHPLC Method for the Estimation of Rosuvastatin and Its Complete Impurity Profile in Tablet Formulations
por: Mammone, Francesca Romana, et al.
Publicado: (2023)

Analytical Study for the Charge-Transfer Complexes of Rosuvastatin Calcium with π-Acceptors
por: Alzoman, Nourah Z., et al.
Publicado: (2013)

Characterization of Novel Cement-Based Carboxymethyl Chitosan/Amorphous Calcium Phosphate
por: Putranto, Aditya Wisnu, et al.
Publicado: (2022)

Itraconazole Amorphous Solid Dispersion Tablets: Formulation and Compaction Process Optimization Using Quality by Design Principles and Tools
por: Triboandas, Hetvi, et al.
Publicado: (2022)

Development of co-processed excipients in the design and evaluation of atorvastatin calcium tablets by direct compression method
por: Pusapati, Ravi Teja, et al.
Publicado: (2014)

The Use of Calcium Phosphate-Based Starter Pellets for the Preparation of Sprinkle IR MUPS Formulation of Rosuvastatin Calcium
por: Cal, Krzysztof, et al.
Publicado: (2023)

Design and characterization of controlled release tablet of metoprolol
por: Singhvi, Gautam, et al.
Publicado: (2012)

The Bioequivalence and Effect of Food on the Pharmacokinetics of a Fixed‐Dose Combination Tablet Containing Rosuvastatin and Ezetimibe in Healthy Japanese Subjects
por: Nishida, Chisato, et al.
Publicado: (2019)

Homogenization of Amorphous Solid Dispersions Prepared by Electrospinning in Low-Dose Tablet Formulation
por: Fülöp, Gergő, et al.
Publicado: (2018)

Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs
por: Mudie, Deanna M., et al.
Publicado: (2021)

Defining the process parameters affecting the fabrication of rosuvastatin calcium nanoparticles by planetary ball mill
por: Alshora, Doaa, et al.
Publicado: (2019)

Current Perspectives on rosuvastatin
por: Hu, Miao, et al.
Publicado: (2013)

Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma
por: Darwish, Ibrahim A, et al.
Publicado: (2011)

Amorphous calcium phosphate and its application in dentistry
por: Zhao, Jie, et al.
Publicado: (2011)

Crystallization kinetics of amorphous calcium carbonate in confinement
por: Cavanaugh, Jack, et al.
Publicado: (2019)

Effectiveness and Safety of a Fixed-Dose Combination of Valsartan and Rosuvastatin (Rovatitan(®) Tablet) in Patients with Concomitant Hypertension and Hyperlipidemia: An Observational Study
por: Lee, Kwang Je, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0tt7u0sf0trc5unko056g1flc7